Security Snapshot

Cigna Group - Common Stock (CI) Institutional Ownership

CUSIP: 125523100

13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

1,630

Shares (Excl. Options)

235,102,843

Price

$275.23

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock
Symbol
CI on NYSE
Shares outstanding
263,665,892
Price per share
$266.75
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
235,102,843
Total reported value
$64,713,297,492
% of total 13F portfolios
0.04%
Share change
+2,009,650
Value change
+$524,166,272
Number of holders
1,630
Price from insider filings
$266.75
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Quick Takeaways

  • CI - Cigna Group - Common Stock is tracked under CUSIP 125523100.
  • 1630 institutions reported positions in Q4 2025.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 1,630 to 361 between Q4 2025 and Q1 2026.
  • Reported value moved from $64,713,297,492 to $1,037,359,666.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 1630 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 125523100?
CUSIP 125523100 identifies CI - Cigna Group - Common Stock in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Cigna Group - Common Stock (CI) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 7.4% $6,687,563,331 19,941,446 BlackRock, Inc. 31 Mar 2025
FMR LLC 4% $3,074,346,505 10,665,556 FMR LLC 30 Sep 2025

As of 31 Dec 2025, 1,630 institutional investors reported holding 235,102,843 shares of Cigna Group - Common Stock (CI). This represents 89% of the company’s total 263,665,892 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Cigna Group - Common Stock (CI) together control 63% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 9.9% 26,173,577 +1.6% 0.1% $7,203,753,597
BlackRock, Inc. 8.8% 23,184,007 +4.9% 0.11% $6,380,934,226
STATE STREET CORP 4.7% 12,339,250 +1.8% 0.11% $3,396,131,778
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 4.5% 11,805,083 +8.3% 1% $3,249,112,994
FMR LLC 4.3% 11,433,649 +7.2% 0.16% $3,146,883,422
Dodge & Cox 4.2% 11,138,614 +20% 1.7% $3,065,680,742
Sanders Capital, LLC 3% 7,801,089 -0.35% 2.5% $2,147,093,725
GQG Partners LLC 2.9% 7,763,295 +14% 3.5% $2,136,698,563
PRICE T ROWE ASSOCIATES INC /MD/ 2.4% 6,270,213 -45% 0.19% $1,725,752,000
GEODE CAPITAL MANAGEMENT, LLC 2.3% 6,051,370 +0.81% 0.1% $1,658,054,581
JPMORGAN CHASE & CO 2.1% 5,639,215 -15% 0.1% $1,552,081,573
NORGES BANK 1.4% 3,705,227 0.11% $1,019,789,627
MORGAN STANLEY 1.3% 3,387,860 -8% 0.06% $932,441,729
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.1% 2,958,656 +9.8% 0.48% $814,310,891
BANK OF AMERICA CORP /DE/ 1.1% 2,925,406 +3.4% 0.06% $805,159,582
NORTHERN TRUST CORP 1% 2,751,024 -2.7% 0.1% $757,164,336
AMERIPRISE FINANCIAL INC 0.93% 2,443,642 +14% 0.15% $672,566,887
Invesco Ltd. 0.92% 2,421,775 +27% 0.1% $666,545,180
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 0.88% 2,325,173 +1% 0.14% $639,957,366
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.83% 2,192,063 +4% 0.09% $603,321,532
DIMENSIONAL FUND ADVISORS LP 0.83% 2,189,878 +2.6% 0.13% $602,747,274
Legal & General Group Plc 0.77% 2,036,852 +1.3% 0.12% $560,602,783
Nuveen, LLC 0.76% 2,014,163 +14% 0.15% $554,358,083
Grantham, Mayo, Van Otterloo & Co. LLC 0.74% 1,958,134 +20% 1.4% $538,937,572
Capital Research Global Investors 0.73% 1,933,645 -39% 0.1% $532,197,113

Institutional Holders of Cigna Group - Common Stock (CI) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 3,879,946 $1,037,359,666 +$111,313,954 $266.75 361
2025 Q4 235,102,843 $64,713,297,492 +$524,166,272 $275.23 1,630
2025 Q3 232,976,544 $67,167,655,682 -$857,214,956 $288.25 1,598
2025 Q2 234,889,680 $77,598,726,972 -$885,212,933 $330.58 1,704
2025 Q1 237,606,738 $78,165,391,200 -$1,629,993,633 $329.00 1,662
2024 Q4 243,110,253 $67,139,294,537 +$149,546,680 $276.14 1,620
2024 Q3 241,501,769 $83,663,034,570 -$782,370,817 $346.44 1,676
2024 Q2 242,938,363 $80,300,760,069 -$2,109,254,634 $330.57 1,640
2024 Q1 249,797,666 $90,679,981,393 -$1,122,160,345 $363.19 1,636
2023 Q4 254,905,490 $76,350,472,759 -$323,521,351 $299.45 1,607
2023 Q3 255,571,910 $73,157,868,502 -$415,321,371 $286.07 1,478
2023 Q2 256,478,311 $71,887,572,718 +$121,205,524 $280.60 1,472
2023 Q1 256,474,460 $65,550,273,339 -$1,402,712,627 $255.53 1,457
2022 Q4 261,971,976 $86,695,724,570 -$2,552,637,868 $331.34 1,529
2022 Q3 270,855,350 $75,242,136,697 -$1,620,088,258 $277.47 1,452
2022 Q2 276,429,732 $72,853,453,449 -$283,725,559 $263.52 1,410
2022 Q1 278,899,427 $66,890,029,883 -$1,137,305,493 $239.61 1,346
2021 Q4 283,619,322 $65,152,838,427 -$1,812,537,350 $229.63 1,307
2021 Q3 291,305,903 $58,341,683,644 -$2,024,570,950 $200.16 1,219
2021 Q2 300,814,030 $71,290,214,867 -$1,665,379,799 $237.07 1,262
2021 Q1 307,283,997 $74,271,008,939 -$1,668,241,583 $241.74 1,216
2020 Q4 315,379,158 $65,634,524,310 -$626,660,034 $208.18 1,175
2020 Q3 319,448,567 $54,030,116,575 -$2,336,334,165 $169.41 1,089
2020 Q2 332,373,272 $62,333,055,611 +$389,410,042 $187.65 1,131
2020 Q1 330,640,915 $58,568,219,801 -$573,938,971 $177.18 1,105
2019 Q4 333,347,680 $68,149,790,920 +$764,945,588 $204.49 1,148
2019 Q3 328,919,099 $49,917,839,260 -$549,118,085 $151.79 1,018
2019 Q2 332,629,799 $52,411,348,146 -$84,749,971 $157.55 1,031
2019 Q1 336,095,513 $54,037,429,873 +$225,933,374 $160.82 1,063
2018 Q4 332,747,054 $63,187,552,217 +$63,024,351,645 $189.92 1,117
2018 Q3 3,821 $738,099 +$4,998 $208.25 6
2018 Q2 3,797 $669,426 -$1,436,787 $169.95 6
2018 Q1 12,737 $2,101,708 +$1,476,355 $167.74 7
2017 Q4 3,562 $675,935 -$24,108 $202.69 6
2017 Q3 3,681 $676,005 +$386,000 $186.94 6
2017 Q2 1,549 $258,553 +$7,500 $167.39 5
2017 Q1 1,504 $220,757 -$5,024 $146.49 5
2016 Q4 1,538 $204,723 -$12,735 $133.39 5
2016 Q3 1,419 $184,432 -$6,516 $130.15 4
2016 Q2 1,092 $140,000 -$134,560 $127.99 3
2016 Q1 2,014 $288,594 $137.47 4